More studies demonstrate the anti-obesity and anti-diabetic effects of 20-hydroxyecdysone
Most recent studies in Rutgers University (USA) once more shows strong influence of 20-hydroxyecdysone (20HE) on the fat burning process. Daily oral administration of 20HE (10 mg/kg for 13 wk) ameliorated obesity and insulin resistance in mice fed a high-fat diet and produced a significant decrease of body weight gain and body fat mass compared with nontreated animals as demonstrated by dual-energy X-ray absorptiometry analysis. In addition, plasma insulin levels and glucose tolerance were significantly lowered by 20HE treatment. These changes were accompanied by the reduced hepatic expression of PEPCK and G6Pase and increased adiponectin production by visceral fat tissue. Ecdysten contains 5mg of 20-Hydroxyecdysone.